videos
On-demand library.
.png)
October 24, 2024
Improving Accuracy and Efficiency Leveraging a Human Pangenome Reference Webinar.
What will you learn in this webinar:
- Enhanced Genomic Accuracy: See how pangenome references improve equity, scientific rigor, and clinical utility over standard methods.
- Superior Alignment: Learn how better sequencing read alignment leads to more accurate variant calling, particularly in complex regions like MHC.
- Efficiency Gains: Understand how these technologies cut computational costs and time, removing the need for expensive joint calling.
watch here
.svg)
October 2, 2024
The Variant Interpretation for Cancer Consortium (VICC) - FDA LDT Discussion
Drs. Eric Konnick, Yassmine Akkari, and Andy Bredemeyer discuss the recent decisions and actions surrounding FDA governance of laboratory developed tests (LDTs) - the Final Rule, current lawsuits, and what it all means for those of us in cancer genomics.
watch here
.gif)
October 3, 2024
Optimizing RCM with 2024 CPT Code Updates.
Explore how the new 2024 CPT codes could impact your organization's reimbursement rates, along with the latest trends in NGS reimbursement and insights into the Medicare Gapfill process. We also discuss how Velsera can help your organization maximize reimbursement and streamline your revenue cycle management workflow.
watch here
October 24, 2024
Improving Accuracy and Efficiency Leveraging a Human Pangenome Reference Webinar.
What will you learn in this webinar:
- Enhanced Genomic Accuracy: See how pangenome references improve equity, scientific rigor, and clinical utility over standard methods.
- Superior Alignment: Learn how better sequencing read alignment leads to more accurate variant calling, particularly in complex regions like MHC.
- Efficiency Gains: Understand how these technologies cut computational costs and time, removing the need for expensive joint calling.
watch here
October 2, 2024
The Variant Interpretation for Cancer Consortium (VICC) - FDA LDT Discussion
Drs. Eric Konnick, Yassmine Akkari, and Andy Bredemeyer discuss the recent decisions and actions surrounding FDA governance of laboratory developed tests (LDTs) - the Final Rule, current lawsuits, and what it all means for those of us in cancer genomics.
watch here
October 3, 2024
Optimizing RCM with 2024 CPT Code Updates.
Explore how the new 2024 CPT codes could impact your organization's reimbursement rates, along with the latest trends in NGS reimbursement and insights into the Medicare Gapfill process. We also discuss how Velsera can help your organization maximize reimbursement and streamline your revenue cycle management workflow.
watch here
SEE VELSERA IN ACTION
Ask what’s possible with Velsera.
